NXGN:NGS-NextGen Healthcare Inc.

EQUITY | Application Software | Nasdaq Global Select

Last Closing Price

USD 18.71

Change

-0.30 (-1.58)%

Market Cap

USD 1.21B

Volume

0.23M

Average Target Price

USD 19.00 (+1.55%)
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-06-25 )

Largest Industry Peers for Application Software

Symbol Name Price(Change) Market Cap
MSFT Microsoft Corporation

-4.35 (-3.16%)

USD 1,022.45B
ADBE Adobe Inc.

-11.90 (-3.97%)

USD 140.52B
INTU Intuit Inc.

-4.85 (-1.85%)

USD 66.75B
WDAY Workday Inc.

-4.55 (-2.18%)

USD 46.22B
CTSH Cognizant Technology Solutions..

-0.89 (-1.39%)

USD 35.96B
ADSK Autodesk Inc.

-5.34 (-3.17%)

USD 35.83B
ATVI Activision Blizzard Inc

-0.95 (-2.01%)

USD 35.39B
TEAM Atlassian Corporation Plc

-4.81 (-3.68%)

USD 30.31B
EA Electronic Arts Inc.

-2.10 (-2.12%)

USD 28.72B
CERN Cerner Corporation

-1.40 (-1.93%)

USD 23.19B

ETFs Containing NXGN

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Application Software)
Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.50% 55% F 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.50% 55% F 74% C
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 1.21B 55% F 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Application Software)
Ratio vs. Market
(Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 133.64 6% F 3% F
Price/Book Ratio 3.41 56% F 31% F
Price / Cash Flow Ratio 5.54 39% F 15% F
Price/Free Cash Flow Ratio 41.58 24% F 10% F
Management Effectiveness  
Return on Equity 2.76% 53% F 49% F
Return on Invested Capital 2.69% 50% F 52% F
Return on Assets 1.80% 60% D- 67% D+
Debt to Equity Ratio 11.00% 74% C 75% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector